Articles published by Applied BioCode

Applied BioCode Announces FDA Clearance for KingFisher™ Nucleic Acid Extraction with BioCode® Respiratory Pathogen Panel for IVD Use

Today 6:00 EDT

From Applied BioCode

Via Business Wire

Applied BioCode Submits BioCode® Respiratory Pathogen Panel (RPP) with KingFisher™ Nucleic Acid Extraction Claim to the FDA

December 22, 2025

From Applied BioCode

Via Business Wire

Applied BioCode Appoints Industry Veteran Beth Laderman as Chief Scientific Officer

September 28, 2023

From Applied BioCode

Via Business Wire

Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use

June 12, 2023

From Applied BioCode

Via Business Wire

Applied BioCode Announces Distribution Agreement with Medline Industries

May 08, 2023

From Applied BioCode

Via Business Wire

Applied BioCode Announces 2022 Q4 and Full year Revenue

February 27, 2023

From Applied BioCode

Via Business Wire

Applied BioCode Appoints Industry Veteran Chris Bernard as Chief Executive Officer

March 24, 2022

From Applied BioCode

Via Business Wire

Applied BioCode Announces Exclusive Partner Distribution Agreement with Hardy Diagnostics, Further Broadens Reach of BioCode® MDx-3000 System into Hospitals and Reference Laboratories in the United States

March 14, 2022

From Applied BioCode

Via Business Wire

Applied BioCode Obtains Emergency Use Authorization for CoV-2 Flu Plus Assay

December 16, 2021

From Applied BioCode

Via Business Wire

Applied BioCode Launches 28 New Fungal Analyte Specific Reagents in the US

November 22, 2021

From Applied BioCode

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.